Last reviewed · How we verify

NCT03566862

Audio Technology To Detect Lung Cancer Earlier

Status unknown Last updated 25 June 2018
What this trial tests

trial testing Leicester Cough Monitor (LCM) in Lung Neoplasms in 20 participants. Status unknown.

Timeline
16 May 2017
Primary endpoint
30 November 2018
30 November 2018

Quick facts

Lead sponsorNHS Greater Glasgow and Clyde
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date16 May 2017
Primary completion30 November 2018
Estimated completion30 November 2018
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

NHS Greater Glasgow and Clyde — full company profile →

Who can join

50 and older, any sex, with Lung Neoplasms or Cough. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A cross-sectional study of prospectively collected cough audio recordings using spectral analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lung Neoplasms

Currently open trials in the same condition.

Other NHS Greater Glasgow and Clyde trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03566862.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing